Sort
82,697 grants matching “vaccine development”
A novel nanochannel system for sustained delivery of Tenofovir Alafenamide Fumarate and Emtricitabine for HIV pre-exposure prophylaxis
$761,083Alessandro Grattoni · Methodist Hospital Research Institute · R01 · FY2020 · AI
PROmotion of COVid-19 VA(X)ccination in the Emergency Department - PROCOVAXED
$761,059Robert Rodriguez · University Of California, San Francisco · R01 · FY2021 · AI
Tfh dysfunction in HIV and Aging
$761,028Savita Pahwa · University Of Miami School Of Medicine · R01 · FY2020 · AG
A Cytomegalovirus-based Vaccine Targeting the Pre-erythrocytic Stage of Malaria
$760,985Klaus J Frueh · Oregon Health & Science University · R01 · FY2019 · AI
RNA Metabolism in Trypanosomes
$760,910Christian Tschudi · Yale University · R01 · FY2019 · AI
The Role of Nasal Mucosal Immunity and Microbiome on the Frequent Exacerbation Phenotype of COPD
$760,907Michael Bradley Drummond · Univ Of North Carolina Chapel Hill · R01 · FY2023 · HL
Heterosubtypic immunity to influenza virus mediated by MHC-E-restricted memory NK cells
$760,892Stephanie Jost · Duke University · R01 · FY2024 · AI
Innate Immune Control of West Nile Virus
$760,880Michael J Gale · University Of Washington · R01 · FY2015 · AI
Innate Immune Control of West Nile Virus
$760,880Michael J Gale · University Of Washington · R01 · FY2016 · AI
Innate Immune Control of West Nile Virus
$760,880Michael J Gale · University Of Washington · R01 · FY2017 · AI
Human Antibodies to HIV-1 by Repertoire Cloning
$760,703Dennis R. Burton · Scripps Research Institute, The · R01 · FY2010 · AI
Mali International Center for Excellence in Research: Malaria Clinical Research
$760,681Ruth Ellis · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Advances in Biotechnology and Their Potential Applications
$760,668Eileen Choffnes · National Academy Of Sciences · · FY2003 · BIO
Epigenetics of severe asthma
$760,658Pandurangan Vijayanand · La Jolla Institute For Immunology · R01 · FY2019 · HL
Impact of Early-life Exposure to Semi-Volatile Organic Compounds (SVOCs) on Neonatal and Early Childhood Immune Function
$760,647Jennifer K Hoffman · Duke University · R01 · FY2024 · AI
Bronx-Lebanon Hospital Center Pediatric ACTU
$760,635Bronx-Lebanon Hosp Ctr (Bronx, Ny) · U01 · FY2004 · AI
Identification of novel immunogenic proteins from Bordetella pertussis
$760,632Purnima Dubey · Ohio State University · R01 · FY2025 · AI
Identification of novel immunogenic proteins from Bordetella pertussis
$760,632Purnima Dubey · Ohio State University · R01 · FY2024 · AI
Identification of novel immunogenic proteins from Bordetella pertussis
$760,632Purnima Dubey · Ohio State University · R01 · FY2023 · AI
Preclinical development of human CMV vaccines
$760,622Michael A McVoy · Virginia Commonwealth University · R01 · FY2010 · AI
Vaccines, Immunoprophylaxis, and Immunotherapy for Coronaviruses
$760,593Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
CD8+ T cell effector transcriptional programming in SIV infection
$760,381Michael R Betts · University Of Pennsylvania · R56 · FY2013 · AI
Novel diagnostic tools and animal model system for study human/animal interface of COVID-19
$760,378Ying Fang · University Of Illinois At Urbana-Champaign · R01 · FY2024 · AI
Mechanism of action and therapeutic utility of immunostimulatory CpG oligonucleo
$760,248Dennis Klinman · Basic Sciences · Z01 · FY2007 · CA
New Cancer Vaccine Technology Based on DRibbles Produced by Tumor Cells
$760,163Sandra Aung · Ubivac, Llc · R44 · FY2009 · CA